Open Pharma April 2021 roundtable meeting report.pdf (818.13 kB)
April 2021 virtual Open Pharma roundtable meeting report
Version 2 2021-06-08, 15:20
Version 1 2021-06-08, 14:26
online resource
posted on 2021-06-08, 15:20 authored by Francesca OunsworthFrancesca Ounsworth, Caitlin Edgell, Tim KoderTim Koder, Tanya Stezhka, Sarah Hewitt, Zoe WattsZoe Watts, Paul Farrow, Chris WinchesterOn 23 April 2021, Members, Supporters and Advisers of Open Pharma and a group of publishing company representatives met for a virtual roundtable meeting to:
1. identify the benefits and risks to pharma, publishers and wider stakeholders in healthcare of open access (OA) agreements between pharma and publishers
2. agree whether there is a role for Open Pharma in future discussions on this topic.
